Pepticom
Business Services · Israel · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Building 2/1 hi-Tech Park Edmond J. Safr...Phone Number
+972 549554990Website
www.pepticom.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Pepticom
Pepticom designs novel peptide drug candidates using biocomputational AI software to optimize the discovery process, accelerate time to market, and reduce development risks and costs. Their mission is to advance 21st-century medicine by improving access to novel peptide therapeutics. Pepticom utilizes AI-driven technologies to discover better binding peptides for target interactions and offers a proprietary platform for designing superior drug candidates in various chemical structures. The company focuses on collaborations and in-house development projects in the discovery stage to accelerate drug innovation.Explore more
Pepticom Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Pepticom your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Pepticom is spiking on competitors!
Funding: Get notified immidiatlly once Pepticom has new funding data
Congratulate Masked Content for being promoted to Masked Content at Pepticom
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Pepticom had a recent Job posting/layoffs
Product Launch: Get notified when Pepticom launches new products
Check if Pepticom has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Pepticom recently announced quarterly report
Pepticom, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Pepticom
Find more new buyers
Company Profile Activity
Activity Insights
Pepticom is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Pepticom is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Pepticom.
Pepticom financials insights
Gather financial insights about Pepticom, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Series A
$5M
2021
Other Financing Round
$2.6M
2025
Series A
$6.6M
Pepticom Tech Stack
A closer look at the technologies used by Pepticom
See more technologies
Most Recent Scoops
Funding
Funding
Funding
Funding
Funding
Funding
Pepticom News & Media
Jerusalem-based AI drug design firm Pepticom raises $2.6 million to focus on COVID-19 treatments via PeptiCov
Realising that we’re all going to be living side by side with the SARS-Cov-2 virus for the next foreseeable future, Israeli AI powered drug design and discovery company Pepticom has raised $2.6 million to spin out PeptiCov. The investment is powered by previous investor The Chartered Group. “Unfortunately, Covid-19 and the various viral mutations will […] The post Jerusalem-based AI drug design firm Pepticom raises $2.6 million to focus on COVID-19 treatments via PeptiCov appearedIsraeli AI tech startup Pepticom raises $5M Series A to accelerate drug discovery
Peptides are used in various therapies, and are recognized for being highly selective and efficacious as well as relatively safe. The pharma industry has recently shown an increased interest in peptide research and development, leading to a resurgence of peptide […] The post Israeli AI tech startup Pepticom raises $5M Series A to accelerate drug discovery appeared first on Startups News | Tech News.Pepticom Secures $5M in Series A Funding
Pepticom, a Jerusalem, Israel-based startup that uses AI to accelerate drug discovery, raised $5m in Series A funding. The Chartered Group made the strategic investment. The company intends to use the funds for the development of new AI models to further increase molecular discovery efficacy while reducing risk for the next stages of development. Led […] The post Pepticom Secures $5M in Series A Funding appeared first on FinSMEs.Pepticom Raises $5 Million in Series A Funding
JERUSALEM, Oct. 24, 2019 /PRNewswire/ -- Pepticom, a leader in artificial intelligence peptide drug discovery, announced today that it has secured $5 million in Series A funding from the Chartered Group. Pepticom's unique artificial intelligence (AI) technology streamlines and...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Pepticom
Sign Up For FreeTo access detailed company insights
Pepticom designs novel peptide drug candidates using biocomputational AI software to optimize the discovery process, accelerate time to market, and reduce development risks and costs. Their mission is to advance 21st-century medicine by improving access to novel peptide therapeutics. Pepticom utilizes AI-driven technologies to discover better bindi... Read More
